Delivery Order SPE2DB20D2001-SPE2DB25FPLVR
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,554.64 firm fixed price delivery order is for the supply of 4,564,702,627 units of the medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,775.78 Firm Fixed Price Delivery Order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,145.40 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,505.61 firm fixed-price delivery order is for 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of November 7, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $12,814.44 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract has a firm fixed price of $2,265.51 and a completion date of January 24, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $4,803.88 and a period of performance through June 7, 2024. This contract is not designated as a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,120.82, is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg. The contract is a Firm Fixed Price Delivery Order with a completion date of July 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,057.83, is for the supply of 1,000 capsules of Tamsulosin Hydrochloride 0.4 mg, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of July 19, 2024. This award is part of AmerisourceBergen's larger...
This federal contract award, valued at $1,897.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,758,933 units of Tamsulosin HCL 0.4 mg capsules, a medication used for the treatment of benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 19, 2024. No set-aside designation was...